Xovoltib 40 Mg

Xovoltib 40 Mg

Xovoltib 40 Mg is a targeted anticancer medication used in the treatment of non-small cell lung cancer (NSCLC), particularly in patients with epidermal growth factor receptor (EGFR) mutations. It contains afatinib, a second-generation tyrosine kinase inhibitor (TKI) that blocks signals responsible for cancer cell growth and proliferation. This higher-strength formulation is commonly prescribed as a standard starting dose in eligible patients. In treatment planning, intermediate doses like Xovoltib 30 Mg may be used for dose adjustment, while lower strengths such as Xovoltib 20 Mg are considered in patients requiring reduced dosing due to tolerability concerns.

Mechanism of Action

EGFR Inhibition

Xovoltib 40 Mg works by irreversibly inhibiting EGFR and related receptors involved in cancer cell growth and survival.

Targeted Antitumor Activity

By blocking these pathways, it prevents tumor cell proliferation and promotes cancer cell death. For detailed clinical insights, refer to National Cancer Institute (NCI) and for safety information, consult Mayo Clinic – Afatinib Drug Information.

Medical Uses

Xovoltib 40 Mg is used in:

• EGFR mutation-positive non-small cell lung cancer (NSCLC)
• Advanced or metastatic lung cancer

It is often prescribed as a first-line therapy in appropriate patients.

Dosage and Administration

Xovoltib 40 Mg is typically taken once daily on an empty stomach, as prescribed by an oncologist. The dosage may be adjusted based on patient response and tolerability. In clinical practice, Xovoltib 30 Mg is often used for dose reduction, while Xovoltib 20 Mg may be considered for further adjustment in patients experiencing side effects.

Clinical Effectiveness

Clinical studies have shown that afatinib significantly improves progression-free survival and disease control in patients with EGFR mutation-positive NSCLC. The 40 mg dose is widely used as a standard treatment regimen.

Safety and Side Effects

Common Side Effects

• Diarrhea
• Skin rash
• Mouth sores
• Nail changes

Serious Risks

• Severe diarrhea and dehydration
• Interstitial lung disease
• Liver toxicity

Regular monitoring is essential during therapy. For more details, refer to Mayo Clinic – Afatinib Drug Information.

Contraindications and Precautions

Xovoltib 40 Mg should be used with caution in:

• Patients with lung disorders
• Individuals with liver impairment
• Patients with gastrointestinal conditions

It should not be used during pregnancy unless prescribed by a healthcare provider.

Drug Interactions

Xovoltib 40 Mg may interact with medications affecting liver enzymes and other anticancer drugs. Patients should inform their healthcare provider about all medications they are taking. For research-based insights, refer to National Cancer Institute (NCI).

FAQs